Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CA5BP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
FOXL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CES2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMEM63A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UBR4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDC40 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PCDHGC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EHD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GLI2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PARVB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SOX1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NEUROG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FSCN3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ABLIM3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
JRKL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PAN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TIMP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SERF1B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PTGS1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARFGAP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on